Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Cadernos de Saúde Pública |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000300010 |
Resumo: | The aim of this study was to assess the costs and financial consequences of epidemiological changes in hypertension in México. The cost evaluation method to estimate costs was based on instrumentation techniques. To estimate the epidemiological changes and expected cases of hypertension in 2010-2012, three probabilistic models were constructed according to the Box-Jenkins technique. Comparing the economic impact, from 2010 to 2012 there will be a 24% increase in financial requirements (p < 0.05). The total cost of hypertension in 2011 will be US$ 5,733,350,291, including US$ 2,718,280,941 in direct costs and US$ 3,015,069,350 in indirect costs. If the risk factors and various healthcare models remain unaltered in the institutions analyzed here, the financial consequences will have a major impact on users' pockets, followed by social security providers and public healthcare providers. The authors suggest a revision in the planning, organization, and allocation of resources, particularly programs for health promotion and prevention of hypertension. |
id |
FIOCRUZ-5_25953f65f3fec537d51d75c7d534fd4f |
---|---|
oai_identifier_str |
oai:scielo:S0102-311X2012000300010 |
network_acronym_str |
FIOCRUZ-5 |
network_name_str |
Cadernos de Saúde Pública |
repository_id_str |
|
spelling |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in MexicoFinancial ManagementCosts and Cost AnalysisHypertensionThe aim of this study was to assess the costs and financial consequences of epidemiological changes in hypertension in México. The cost evaluation method to estimate costs was based on instrumentation techniques. To estimate the epidemiological changes and expected cases of hypertension in 2010-2012, three probabilistic models were constructed according to the Box-Jenkins technique. Comparing the economic impact, from 2010 to 2012 there will be a 24% increase in financial requirements (p < 0.05). The total cost of hypertension in 2011 will be US$ 5,733,350,291, including US$ 2,718,280,941 in direct costs and US$ 3,015,069,350 in indirect costs. If the risk factors and various healthcare models remain unaltered in the institutions analyzed here, the financial consequences will have a major impact on users' pockets, followed by social security providers and public healthcare providers. The authors suggest a revision in the planning, organization, and allocation of resources, particularly programs for health promotion and prevention of hypertension.Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz2012-03-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000300010Cadernos de Saúde Pública v.28 n.3 2012reponame:Cadernos de Saúde Públicainstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZ10.1590/S0102-311X2012000300010info:eu-repo/semantics/openAccessArredondo,ArmandoZuñiga,Alexiseng2012-03-12T00:00:00Zoai:scielo:S0102-311X2012000300010Revistahttp://cadernos.ensp.fiocruz.br/csp/https://old.scielo.br/oai/scielo-oai.phpcadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br1678-44640102-311Xopendoar:2012-03-12T00:00Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
title |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
spellingShingle |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico Arredondo,Armando Financial Management Costs and Cost Analysis Hypertension |
title_short |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
title_full |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
title_fullStr |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
title_full_unstemmed |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
title_sort |
Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico |
author |
Arredondo,Armando |
author_facet |
Arredondo,Armando Zuñiga,Alexis |
author_role |
author |
author2 |
Zuñiga,Alexis |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Arredondo,Armando Zuñiga,Alexis |
dc.subject.por.fl_str_mv |
Financial Management Costs and Cost Analysis Hypertension |
topic |
Financial Management Costs and Cost Analysis Hypertension |
description |
The aim of this study was to assess the costs and financial consequences of epidemiological changes in hypertension in México. The cost evaluation method to estimate costs was based on instrumentation techniques. To estimate the epidemiological changes and expected cases of hypertension in 2010-2012, three probabilistic models were constructed according to the Box-Jenkins technique. Comparing the economic impact, from 2010 to 2012 there will be a 24% increase in financial requirements (p < 0.05). The total cost of hypertension in 2011 will be US$ 5,733,350,291, including US$ 2,718,280,941 in direct costs and US$ 3,015,069,350 in indirect costs. If the risk factors and various healthcare models remain unaltered in the institutions analyzed here, the financial consequences will have a major impact on users' pockets, followed by social security providers and public healthcare providers. The authors suggest a revision in the planning, organization, and allocation of resources, particularly programs for health promotion and prevention of hypertension. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-03-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000300010 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000300010 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0102-311X2012000300010 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
publisher.none.fl_str_mv |
Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz |
dc.source.none.fl_str_mv |
Cadernos de Saúde Pública v.28 n.3 2012 reponame:Cadernos de Saúde Pública instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Cadernos de Saúde Pública |
collection |
Cadernos de Saúde Pública |
repository.name.fl_str_mv |
Cadernos de Saúde Pública - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
cadernos@ensp.fiocruz.br||cadernos@ensp.fiocruz.br |
_version_ |
1754115732404174848 |